Marketing, Licensing and Distribution Agreements - Vivus (Details)		3 Months Ended		12 Months Ended
	Sep. 30, 2016 USD ($)	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)	Dec. 31, 2022 USD ($)	Jan. 18, 2022 USD ($)
Marketing, Licensing and Distribution Agreements
Noncash decrease in accrued expenses related to Vivus settlement			$ (6,520,283)
Noncash decrease in API purchase commitment		$ 228,001	6,232,489
Noncash decrease in accrued inventory purchases related to Vivus Settlement			(14,203,905)
Gain on settlement with Vivus			3,389,941
API purchase commitment asset		673,944		$ 663,984
License Agreement | Royalty on the first $500 million of net sales
Marketing, Licensing and Distribution Agreements
Threshold net sales		500,000,000
License Agreement | Milestone payment to be paid once $250 million in sales has been reached
Marketing, Licensing and Distribution Agreements
Threshold net sales		250,000,000
Milestone payment		6,000,000
License Agreement | Milestone payment to be paid after $250 million in sales has been reached
Marketing, Licensing and Distribution Agreements
Threshold net sales		250,000,000
Milestone payment		$ 3,200,000
License Agreement | Vivus, Inc
Marketing, Licensing and Distribution Agreements
One-time fee to purchase and receive the license for the commercialization and exploitation of Stendra	$ 70,000,000
License Agreement | Vivus, Inc | Royalty during the first, second, and third years following the expiration of the Royalty Period
Marketing, Licensing and Distribution Agreements
Royalty percentage		2.00%
License Agreement | Vivus, Inc | Royalty following the fourth and fifth years following the end of the Royalty Period
Marketing, Licensing and Distribution Agreements
Royalty percentage		1.00%
License Agreement | MTPC
Marketing, Licensing and Distribution Agreements
Royalty incurred		$ 75,314	76,238
Royalty receivable		$ 30,801		106,115
License Agreement | MTPC | Royalty on the first $500 million of net sales
Marketing, Licensing and Distribution Agreements
Royalty percentage		5.00%
License Agreement | MTPC | Royalty on net sales after $500 million
Marketing, Licensing and Distribution Agreements
Royalty percentage		6.00%
Settlement Agreement | Vivus, Inc
Marketing, Licensing and Distribution Agreements
Inventory amount retained - API					$ 7,300,000
Prepayment amount					900,000
Noncash decrease in accrued expenses related to Vivus settlement				6,500,000
Noncash decrease in API purchase commitment		$ 6,200,000
Noncash decrease in accrued inventory purchases related to Vivus Settlement			$ 14,200,000
Payment made for purchase order					$ 1,542,904
Percentage of stendra tablets released					100
Gain on settlement with Vivus				3,400,000
Accrued inventory purchases		0		0
Raw materials inventory		500,000
Settlement Agreement | Vivus, Inc | Other Current Assets
Marketing, Licensing and Distribution Agreements
API purchase commitment asset		700,000		700,000
Settlement Agreement | Vivus, Inc | Other Noncurrent Assets
Marketing, Licensing and Distribution Agreements
Accrued inventory purchases, other assets		4,900,000		$ 5,100,000
Settlement Agreement | Vivus, Inc | Promissory Note
Marketing, Licensing and Distribution Agreements
Prepayment amount					$ 900,000
Principal amount of notes payable		$ 10,200,000			$ 10,201,758